Cogent Biosciences, Inc. (COGT)

37.06 -0.18 (-0.48%) USD  |  NASDAQ  |  Mar 04, 16:00
37.05 -0.01 (-0.03%) After-Hours: 20:00
More

Cogent Biosciences Research and Development Expense (Annual) : 265.16M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Merck & Co., Inc. 12.51B
Sarepta Therapeutics, Inc. 1.496B
BridgeBio Pharma, Inc. 451.95M
Olema Pharmaceuticals, Inc. 124.52M
Revolution Medicines, Inc. 978.68M